0001171843-23-001596.txt : 20230310
0001171843-23-001596.hdr.sgml : 20230310
20230310165139
ACCESSION NUMBER: 0001171843-23-001596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230309
FILED AS OF DATE: 20230310
DATE AS OF CHANGE: 20230310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Colleran David
CENTRAL INDEX KEY: 0001646558
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 23724425
MAIL ADDRESS:
STREET 1: 600 TECHNOLOGY PARK DRIVE
STREET 2: SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0306
4
2023-03-09
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001646558
Colleran David
32 WIGGINS AVENUE
BEDFORD
MA
01730
0
1
0
0
EVP, General Counsel, Corp Sec
Common Stock
2023-03-09
4
M
0
3683
0
A
15956
D
Common Stock
2023-03-09
4
F
0
1081
26.91
D
14875
D
Restricted Stock Unit
0.00
2023-03-09
4
A
0
16395
0
A
Common Stock
16395
16395
D
Stock Option (Right to Buy)
29.60
2023-03-09
4
A
0
35790
0
A
2033-03-09
Common Stock
35790
35790
D
Restricted Stock Unit
0.00
2023-03-09
4
M
0
3683
0
D
Common Stock
3683
3682
D
Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
Reflects an aggregate of 1,081 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023.
Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
The premium priced stock options vest in three equal annual installments beginning on March 9, 2024.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
/s/ David Colleran
2023-03-10